Dr. Aoife Campbell is a translational scientist with over eight years of experience across academia and the biotechnology industry. She holds a PhD in Neuroscience from the FutureNeuro Research Centre, where her work with Roche focused on developing novel therapeutics for rare neurodevelopmental disorders. After postdoctoral research in neurobiology and circadian regulation, she joined Healx and Turbine, contributing to drug discovery in rare diseases and oncology. Aoife brings this expertise to the ARC Hub as Portfolio Manager, liaising with RCSI, bridging preclinical research, translational strategy, and data-driven drug development to advance collaborative and impactful research initiatives.
Innovation Training for ARC Hub for Therapeutics Translational Researchers
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
